Biocon Biologics Biocon Campus (Site 1) facility gets 4 USFDA observations Ruchika Sharma1 March 2024 12:01 PM ISTBangalore: Biocon has recently announced that the U.S. Food and Drug Administration (USFDA) has issued Form 483s with 4 observations at...
Biocon receives over Rs 3 crore penalty over GST related issues Ruchika Sharma24 Feb 2024 4:30 PM ISTNew Delhi: Biocon Ltd has said it has been imposed a penalty of over Rs 3 crore over GST-related issues. The company has received an order of...
Biocon registers consolidated revenue of Rs 4519 crore in Q3 Ruchika Sharma9 Feb 2024 4:03 PM ISTBengaluru: Bengaluru, Biocon Ltd, the Bengaluru-based pharmaceutical giant has announced its consolidated financial results for the fiscal third...
Biocon Biologics, Sandoz Australia ink pact for biosimilars Trastuzumab, Bevacizumab Ruchika Sharma9 Feb 2024 12:30 PM ISTTrastuzumab is a biosimilar of Herceptin and Bevacizumab is a biosimilar of Avastin - both biosimilars are available on the PBS and utilised for the...
USFDA gives tentative nod to Biocon for cancer drug Dasatinib Ruchika Sharma7 Feb 2024 12:43 PM ISTBangalore: Biocon Limited has received tentative approval of its Abbreviated New Drug Application (ANDA) for Dasatinib tablets from the United...
Powered by innovative drugs, pharma industry can be worth USD 200 billion by 2030: Biocon Chief Ruchika Sharma25 Jan 2024 12:17 PM ISTMazumdar-Shaw also sought that the government ought to decouple private sector investment and ensure that academic research institutes are funded out...
Biocon associate co Bicara Therapeutics raises over Rs 1375 crore in series C financing Ruchika Sharma14 Dec 2023 1:30 PM ISTBoston: Bicara Therapeutics, an associate company of Biocon Limited, has announced the completion of an oversubscribed $165 million Series C...
Biocon arm gets UK MHRA marketing authorisation for ophthalmic drug Yesafili Ruchika Sharma14 Nov 2023 11:29 AM ISTIt is highly similar to the reference product Eylea (aflibercept).
Biocon misses Q2 profit view on higher expenses Ruchika Sharma11 Nov 2023 12:15 PM ISTHyderabad: Indian biopharmaceutical company Biocon reported a smaller-than-expected quarterly profit hurt by higher expenses.The company's...
Biocon Biologics to divest dermatology, nephrology branded formulations business units in India to Eris Lifesciences for Rs 366 crore Ruchika Sharma9 Nov 2023 11:45 AM ISTThe divestiture is expected to close by the end of Nov 2023, subject to customary closing conditions.
Ex Cipla Global CFO Kedar Upadhye appointed as new CFO of Biocon Biologics Ruchika Sharma20 Oct 2023 2:30 PM ISTBengaluru: Biocon Biologics Ltd, a subsidiary of Biocon Ltd has announced that the Board of Directors of Biocon Biologics have appointed Kedar Upadhye...
Biocon Biologics arm gets OAI status from USFDA for Malaysia insulin facility Ruchika Sharma18 Oct 2023 12:30 PM ISTBengaluru: Biocon Sdn Bhd., a step-down subsidiary of Biocon Biologics Limited has received a communication from the U.S. Food and Drug...
